Nomura Holdings’s ResMed RMD Stock Holding History

Nomura Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7M	Buy	54,800 +50,000	+1,042%	+$10.4M	0.01%	523
2026 Q1	$1.08M	Hold	4,800	–	–	﹤0.01%	1134
2025 Q4	$1.16M	Hold	4,800	–	–	﹤0.01%	1281
2025 Q3	$1.31M	Buy	+4,800	New	+$1.31M	﹤0.01%	1305

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nomura Holdings's RMD Position: Q2 2026 in Review

Nomura Holdings increased its ResMed (RMD) stake by 25% in Q2 2026, buying an estimated $1.93M and bringing the position to 46,309 shares worth $9.02M. The position accounts for 0.01% of the portfolio, ranked #576.

Nomura Holdings first reported a position in RMD in Q2 2013 and has held it in 33 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Nomura Holdings held 46,309 shares of ResMed worth $9.02M as of Q2 2026.
Nomura Holdings bought 9,316 ResMed shares in Q2 2026, an estimated $1.93M.
ResMed made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #576 holding.
Nomura Holdings first reported a position in ResMed in Q2 2013 and has held it in 33 quarters since.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.